nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA6—saliva—attention deficit hyperactivity disorder	0.175	0.179	CbGeAlD
Furosemide—SLC12A1—forebrain—attention deficit hyperactivity disorder	0.0321	0.0329	CbGeAlD
Furosemide—CA7—midbrain—attention deficit hyperactivity disorder	0.0284	0.0291	CbGeAlD
Furosemide—CA12—forebrain—attention deficit hyperactivity disorder	0.0279	0.0286	CbGeAlD
Furosemide—PGD—forebrain—attention deficit hyperactivity disorder	0.0264	0.0271	CbGeAlD
Furosemide—CA14—midbrain—attention deficit hyperactivity disorder	0.0236	0.0242	CbGeAlD
Furosemide—PGD—cardiovascular system—attention deficit hyperactivity disorder	0.0223	0.0229	CbGeAlD
Furosemide—CA1—forebrain—attention deficit hyperactivity disorder	0.0221	0.0227	CbGeAlD
Furosemide—CA7—cerebellum—attention deficit hyperactivity disorder	0.0219	0.0225	CbGeAlD
Furosemide—CA5B—cardiovascular system—attention deficit hyperactivity disorder	0.0212	0.0217	CbGeAlD
Furosemide—CA9—cerebellum—attention deficit hyperactivity disorder	0.0193	0.0198	CbGeAlD
Furosemide—CA1—cardiovascular system—attention deficit hyperactivity disorder	0.0187	0.0192	CbGeAlD
Furosemide—CA14—cerebellum—attention deficit hyperactivity disorder	0.0183	0.0187	CbGeAlD
Furosemide—CA7—brain—attention deficit hyperactivity disorder	0.0178	0.0183	CbGeAlD
Furosemide—PGD—midbrain—attention deficit hyperactivity disorder	0.0175	0.0179	CbGeAlD
Furosemide—SLC12A1—nervous system—attention deficit hyperactivity disorder	0.0174	0.0179	CbGeAlD
Furosemide—CA4—forebrain—attention deficit hyperactivity disorder	0.0173	0.0177	CbGeAlD
Furosemide—SLC12A1—central nervous system—attention deficit hyperactivity disorder	0.0168	0.0172	CbGeAlD
Furosemide—SLCO2A1—nervous system—attention deficit hyperactivity disorder	0.0161	0.0165	CbGeAlD
Furosemide—SLCO2A1—central nervous system—attention deficit hyperactivity disorder	0.0155	0.0159	CbGeAlD
Furosemide—CA12—nervous system—attention deficit hyperactivity disorder	0.0151	0.0155	CbGeAlD
Furosemide—CA14—brain—attention deficit hyperactivity disorder	0.0148	0.0152	CbGeAlD
Furosemide—CA4—cardiovascular system—attention deficit hyperactivity disorder	0.0146	0.015	CbGeAlD
Furosemide—CA12—central nervous system—attention deficit hyperactivity disorder	0.0146	0.015	CbGeAlD
Furosemide—PGD—nervous system—attention deficit hyperactivity disorder	0.0143	0.0147	CbGeAlD
Furosemide—CA2—forebrain—attention deficit hyperactivity disorder	0.0143	0.0147	CbGeAlD
Furosemide—PGD—central nervous system—attention deficit hyperactivity disorder	0.0138	0.0142	CbGeAlD
Furosemide—CA5B—nervous system—attention deficit hyperactivity disorder	0.0136	0.0139	CbGeAlD
Furosemide—PGD—cerebellum—attention deficit hyperactivity disorder	0.0135	0.0138	CbGeAlD
Furosemide—SLC12A1—brain—attention deficit hyperactivity disorder	0.0133	0.0137	CbGeAlD
Furosemide—CA5B—central nervous system—attention deficit hyperactivity disorder	0.0131	0.0134	CbGeAlD
Furosemide—SLC22A6—brain—attention deficit hyperactivity disorder	0.0129	0.0133	CbGeAlD
Furosemide—SLCO2A1—brain—attention deficit hyperactivity disorder	0.0123	0.0126	CbGeAlD
Furosemide—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.0121	0.0124	CbGeAlD
Furosemide—CA1—nervous system—attention deficit hyperactivity disorder	0.012	0.0123	CbGeAlD
Furosemide—CA12—brain—attention deficit hyperactivity disorder	0.0116	0.0119	CbGeAlD
Furosemide—CA1—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0118	CbGeAlD
Furosemide—CA4—midbrain—attention deficit hyperactivity disorder	0.0114	0.0117	CbGeAlD
Furosemide—PGD—brain—attention deficit hyperactivity disorder	0.011	0.0112	CbGeAlD
Furosemide—CA5B—brain—attention deficit hyperactivity disorder	0.0104	0.0107	CbGeAlD
Furosemide—SLC22A8—nervous system—attention deficit hyperactivity disorder	0.0101	0.0104	CbGeAlD
Furosemide—SLC22A8—central nervous system—attention deficit hyperactivity disorder	0.00975	0.00999	CbGeAlD
Furosemide—CA2—midbrain—attention deficit hyperactivity disorder	0.00946	0.0097	CbGeAlD
Furosemide—CA4—nervous system—attention deficit hyperactivity disorder	0.00938	0.00962	CbGeAlD
Furosemide—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.00931	0.00954	CbGeAlD
Furosemide—CA1—brain—attention deficit hyperactivity disorder	0.00917	0.00941	CbGeAlD
Furosemide—CA4—central nervous system—attention deficit hyperactivity disorder	0.00903	0.00926	CbGeAlD
Furosemide—CA4—cerebellum—attention deficit hyperactivity disorder	0.00883	0.00905	CbGeAlD
Furosemide—ALB—brain—attention deficit hyperactivity disorder	0.00806	0.00826	CbGeAlD
Furosemide—CA2—nervous system—attention deficit hyperactivity disorder	0.00778	0.00798	CbGeAlD
Furosemide—SLC22A8—brain—attention deficit hyperactivity disorder	0.00774	0.00793	CbGeAlD
Furosemide—CA2—central nervous system—attention deficit hyperactivity disorder	0.00749	0.00768	CbGeAlD
Furosemide—CA2—cerebellum—attention deficit hyperactivity disorder	0.00732	0.00751	CbGeAlD
Furosemide—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.0072	0.00738	CbGeAlD
Furosemide—CA4—brain—attention deficit hyperactivity disorder	0.00717	0.00735	CbGeAlD
Furosemide—CA2—brain—attention deficit hyperactivity disorder	0.00595	0.0061	CbGeAlD
Furosemide—SLC22A5—brain—attention deficit hyperactivity disorder	0.00585	0.006	CbGeAlD
Furosemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.00183	0.0739	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000981	0.0396	CbGpPWpGaD
Furosemide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—attention deficit hyperactivity disorder	0.00097	0.0391	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000819	0.033	CbGpPWpGaD
Furosemide—PGD—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000556	0.0224	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000499	0.0201	CbGpPWpGaD
Furosemide—PGD—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000495	0.02	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000489	0.0197	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000476	0.0192	CbGpPWpGaD
Furosemide—CA9—Cellular response to hypoxia—EP300—attention deficit hyperactivity disorder	0.000428	0.0173	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000416	0.0168	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000412	0.0166	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000397	0.016	CbGpPWpGaD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000374	0.0151	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000373	0.015	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000341	0.0138	CbGpPWpGaD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000315	0.0127	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000311	0.0125	CbGpPWpGaD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000285	0.0115	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000285	0.0115	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000248	0.01	CbGpPWpGaD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000238	0.00961	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000237	0.00956	CbGpPWpGaD
Furosemide—PGD—Disease—STUB1—attention deficit hyperactivity disorder	0.00021	0.00847	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000209	0.00845	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0002	0.00806	CbGpPWpGaD
Furosemide—CA9—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000197	0.00795	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000189	0.00764	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000187	0.00753	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000185	0.00745	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000181	0.00729	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000173	0.007	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00017	0.00686	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000166	0.00671	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000162	0.00652	CbGpPWpGaD
Furosemide—CA14—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000161	0.00648	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000158	0.00638	CbGpPWpGaD
Furosemide—CA6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000157	0.00632	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000157	0.00632	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000153	0.00618	CbGpPWpGaD
Furosemide—PGD—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000151	0.0061	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000151	0.00608	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000146	0.0059	CbGpPWpGaD
Furosemide—CA7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000146	0.0059	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000146	0.00589	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000145	0.00584	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000143	0.00578	CbGpPWpGaD
Furosemide—CA12—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000135	0.00546	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00013	0.00525	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.00523	CbGpPWpGaD
Furosemide—CA14—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000111	0.00448	CbGpPWpGaD
Furosemide—CA14—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000111	0.00448	CbGpPWpGaD
Furosemide—CA14—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000109	0.0044	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000108	0.00437	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000108	0.00436	CbGpPWpGaD
Furosemide—CA6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000108	0.00436	CbGpPWpGaD
Furosemide—CA6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000108	0.00436	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000108	0.00436	CbGpPWpGaD
Furosemide—CA4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000108	0.00436	CbGpPWpGaD
Furosemide—CA6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000106	0.00429	CbGpPWpGaD
Furosemide—CA5A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000106	0.00429	CbGpPWpGaD
Furosemide—PGD—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000104	0.00421	CbGpPWpGaD
Furosemide—PGD—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000104	0.00421	CbGpPWpGaD
Furosemide—CA2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000104	0.00418	CbGpPWpGaD
Furosemide—PGD—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000103	0.00414	CbGpPWpGaD
Furosemide—CA14—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000101	0.00409	CbGpPWpGaD
Furosemide—CA7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000101	0.00407	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000101	0.00407	CbGpPWpGaD
Furosemide—CA7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000101	0.00407	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000101	0.00407	CbGpPWpGaD
Furosemide—PGD—Disease—SNAP25—attention deficit hyperactivity disorder	9.96e-05	0.00402	CbGpPWpGaD
Furosemide—CA7—Metabolism—DPYD—attention deficit hyperactivity disorder	9.93e-05	0.00401	CbGpPWpGaD
Furosemide—CA1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.93e-05	0.00401	CbGpPWpGaD
Furosemide—CA5B—Metabolism—DPYD—attention deficit hyperactivity disorder	9.93e-05	0.00401	CbGpPWpGaD
Furosemide—CA6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.89e-05	0.00399	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.89e-05	0.00399	CbGpPWpGaD
Furosemide—PGD—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.54e-05	0.00385	CbGpPWpGaD
Furosemide—CA12—Metabolism—TPH2—attention deficit hyperactivity disorder	9.35e-05	0.00377	CbGpPWpGaD
Furosemide—CA12—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.35e-05	0.00377	CbGpPWpGaD
Furosemide—CA7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.23e-05	0.00372	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.23e-05	0.00372	CbGpPWpGaD
Furosemide—CA12—Metabolism—DPYD—attention deficit hyperactivity disorder	9.2e-05	0.00371	CbGpPWpGaD
Furosemide—CA14—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.87e-05	0.00358	CbGpPWpGaD
Furosemide—CA9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.73e-05	0.00352	CbGpPWpGaD
Furosemide—CA6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.64e-05	0.00349	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.64e-05	0.00349	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.64e-05	0.00349	CbGpPWpGaD
Furosemide—CA12—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.55e-05	0.00345	CbGpPWpGaD
Furosemide—CA14—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.44e-05	0.00341	CbGpPWpGaD
Furosemide—PGD—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.34e-05	0.00336	CbGpPWpGaD
Furosemide—CA6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.23e-05	0.00332	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.23e-05	0.00332	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	8.21e-05	0.00331	CbGpPWpGaD
Furosemide—CA7—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.07e-05	0.00325	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.07e-05	0.00325	CbGpPWpGaD
Furosemide—PGD—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.94e-05	0.0032	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	7.84e-05	0.00316	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.68e-05	0.0031	CbGpPWpGaD
Furosemide—CA7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.68e-05	0.0031	CbGpPWpGaD
Furosemide—CA12—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.47e-05	0.00302	CbGpPWpGaD
Furosemide—CA4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.46e-05	0.00301	CbGpPWpGaD
Furosemide—CA4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.46e-05	0.00301	CbGpPWpGaD
Furosemide—CA4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.33e-05	0.00296	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.28e-05	0.00294	CbGpPWpGaD
Furosemide—CA2—Metabolism—TPH2—attention deficit hyperactivity disorder	7.15e-05	0.00288	CbGpPWpGaD
Furosemide—CA2—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.15e-05	0.00288	CbGpPWpGaD
Furosemide—CA12—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.11e-05	0.00287	CbGpPWpGaD
Furosemide—CA2—Metabolism—DPYD—attention deficit hyperactivity disorder	7.03e-05	0.00284	CbGpPWpGaD
Furosemide—CA1—Metabolism—TPH2—attention deficit hyperactivity disorder	6.85e-05	0.00276	CbGpPWpGaD
Furosemide—CA1—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.85e-05	0.00276	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	6.84e-05	0.00276	CbGpPWpGaD
Furosemide—CA4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.82e-05	0.00275	CbGpPWpGaD
Furosemide—CA1—Metabolism—DPYD—attention deficit hyperactivity disorder	6.74e-05	0.00272	CbGpPWpGaD
Furosemide—CA14—Metabolism—COMT—attention deficit hyperactivity disorder	6.72e-05	0.00271	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	6.71e-05	0.00271	CbGpPWpGaD
Furosemide—CA14—Metabolism—MAOA—attention deficit hyperactivity disorder	6.67e-05	0.00269	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.59e-05	0.00266	CbGpPWpGaD
Furosemide—CA5A—Metabolism—COMT—attention deficit hyperactivity disorder	6.55e-05	0.00264	CbGpPWpGaD
Furosemide—CA6—Metabolism—COMT—attention deficit hyperactivity disorder	6.55e-05	0.00264	CbGpPWpGaD
Furosemide—CA2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.54e-05	0.00264	CbGpPWpGaD
Furosemide—CA5A—Metabolism—MAOA—attention deficit hyperactivity disorder	6.5e-05	0.00262	CbGpPWpGaD
Furosemide—CA6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.5e-05	0.00262	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	6.5e-05	0.00262	CbGpPWpGaD
Furosemide—PGD—Metabolism—COMT—attention deficit hyperactivity disorder	6.32e-05	0.00255	CbGpPWpGaD
Furosemide—PGD—Metabolism—MAOA—attention deficit hyperactivity disorder	6.27e-05	0.00253	CbGpPWpGaD
Furosemide—CA1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.27e-05	0.00253	CbGpPWpGaD
Furosemide—CA7—Metabolism—COMT—attention deficit hyperactivity disorder	6.11e-05	0.00247	CbGpPWpGaD
Furosemide—CA5B—Metabolism—COMT—attention deficit hyperactivity disorder	6.11e-05	0.00247	CbGpPWpGaD
Furosemide—CA7—Metabolism—MAOA—attention deficit hyperactivity disorder	6.07e-05	0.00245	CbGpPWpGaD
Furosemide—CA5B—Metabolism—MAOA—attention deficit hyperactivity disorder	6.07e-05	0.00245	CbGpPWpGaD
Furosemide—CA9—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.02e-05	0.00243	CbGpPWpGaD
Furosemide—CA9—Metabolism—TPH2—attention deficit hyperactivity disorder	6.02e-05	0.00243	CbGpPWpGaD
Furosemide—CA4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.96e-05	0.0024	CbGpPWpGaD
Furosemide—CA9—Metabolism—DPYD—attention deficit hyperactivity disorder	5.93e-05	0.00239	CbGpPWpGaD
Furosemide—CA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.71e-05	0.00231	CbGpPWpGaD
Furosemide—CA4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.67e-05	0.00229	CbGpPWpGaD
Furosemide—CA12—Metabolism—COMT—attention deficit hyperactivity disorder	5.66e-05	0.00229	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	5.62e-05	0.00227	CbGpPWpGaD
Furosemide—CA12—Metabolism—MAOA—attention deficit hyperactivity disorder	5.62e-05	0.00227	CbGpPWpGaD
Furosemide—CA9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.51e-05	0.00222	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.5e-05	0.00222	CbGpPWpGaD
Furosemide—CA1—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.48e-05	0.00221	CbGpPWpGaD
Furosemide—CA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.44e-05	0.00219	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.33e-05	0.00215	CbGpPWpGaD
Furosemide—CA1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.22e-05	0.0021	CbGpPWpGaD
Furosemide—CA9—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.82e-05	0.00194	CbGpPWpGaD
Furosemide—CA9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.58e-05	0.00185	CbGpPWpGaD
Furosemide—CA4—Metabolism—COMT—attention deficit hyperactivity disorder	4.52e-05	0.00182	CbGpPWpGaD
Furosemide—CA4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.49e-05	0.00181	CbGpPWpGaD
Furosemide—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	4.33e-05	0.00175	CbGpPWpGaD
Furosemide—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	4.3e-05	0.00173	CbGpPWpGaD
Furosemide—CA1—Metabolism—COMT—attention deficit hyperactivity disorder	4.15e-05	0.00168	CbGpPWpGaD
Furosemide—CA1—Metabolism—MAOA—attention deficit hyperactivity disorder	4.12e-05	0.00166	CbGpPWpGaD
Furosemide—CA9—Metabolism—COMT—attention deficit hyperactivity disorder	3.65e-05	0.00147	CbGpPWpGaD
Furosemide—CA9—Metabolism—MAOA—attention deficit hyperactivity disorder	3.62e-05	0.00146	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	3.53e-05	0.00142	CbGpPWpGaD
Furosemide—PGD—Disease—EP300—attention deficit hyperactivity disorder	3.24e-05	0.00131	CbGpPWpGaD
Furosemide—CA14—Metabolism—EP300—attention deficit hyperactivity disorder	2.88e-05	0.00116	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.86e-05	0.00115	CbGpPWpGaD
Furosemide—CA5A—Metabolism—EP300—attention deficit hyperactivity disorder	2.81e-05	0.00113	CbGpPWpGaD
Furosemide—CA6—Metabolism—EP300—attention deficit hyperactivity disorder	2.81e-05	0.00113	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.72e-05	0.0011	CbGpPWpGaD
Furosemide—PGD—Metabolism—EP300—attention deficit hyperactivity disorder	2.71e-05	0.00109	CbGpPWpGaD
Furosemide—CA5B—Metabolism—EP300—attention deficit hyperactivity disorder	2.62e-05	0.00106	CbGpPWpGaD
Furosemide—CA7—Metabolism—EP300—attention deficit hyperactivity disorder	2.62e-05	0.00106	CbGpPWpGaD
Furosemide—CA12—Metabolism—EP300—attention deficit hyperactivity disorder	2.43e-05	0.00098	CbGpPWpGaD
Furosemide—CA4—Metabolism—EP300—attention deficit hyperactivity disorder	1.94e-05	0.000782	CbGpPWpGaD
Furosemide—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	1.88e-05	0.000758	CbGpPWpGaD
Furosemide—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.88e-05	0.000758	CbGpPWpGaD
Furosemide—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	1.86e-05	0.000749	CbGpPWpGaD
Furosemide—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	1.85e-05	0.000746	CbGpPWpGaD
Furosemide—CA1—Metabolism—EP300—attention deficit hyperactivity disorder	1.78e-05	0.000718	CbGpPWpGaD
Furosemide—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.72e-05	0.000693	CbGpPWpGaD
Furosemide—CA9—Metabolism—EP300—attention deficit hyperactivity disorder	1.57e-05	0.000632	CbGpPWpGaD
Furosemide—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.5e-05	0.000606	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.43e-05	0.000577	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	1.2e-05	0.000486	CbGpPWpGaD
Furosemide—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	1.14e-05	0.000459	CbGpPWpGaD
Furosemide—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.13e-05	0.000456	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.1e-05	0.000442	CbGpPWpGaD
Furosemide—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	4.88e-06	0.000197	CbGpPWpGaD
